X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infectious diseases (20) 20
cryptococcal meningitis (18) 18
hiv (18) 18
index medicus (17) 17
humans (15) 15
adult (13) 13
antiretroviral therapy (13) 13
female (13) 13
immunology (13) 13
male (13) 13
mortality (13) 13
meningitis (12) 12
aids (11) 11
microbiology (11) 11
diagnosis (10) 10
uganda (9) 9
fluconazole (7) 7
meningitis, cryptococcal - drug therapy (7) 7
amphotericin-b (6) 6
burden (6) 6
care and treatment (6) 6
cerebrospinal fluid (6) 6
cerebrospinal fluid - microbiology (6) 6
disease (6) 6
flucytosine (6) 6
hiv infection (6) 6
infection (6) 6
meningitis, cryptococcal - mortality (6) 6
research (6) 6
treatment outcome (6) 6
usage (6) 6
aids-related opportunistic infections - mortality (5) 5
antifungal agents - therapeutic use (5) 5
cohort studies (5) 5
human immunodeficiency virus--hiv (5) 5
major (5) 5
prospective studies (5) 5
reconstitution inflammatory syndrome (5) 5
risk factors (5) 5
adults (4) 4
aids-related opportunistic infections - drug therapy (4) 4
amphotericin b (4) 4
antiviral agents (4) 4
clearance (4) 4
colony count, microbial (4) 4
complications and side effects (4) 4
cryptococcus (4) 4
high-dose fluconazole (4) 4
hiv infections - complications (4) 4
randomized-trial (4) 4
survival analysis (4) 4
abridged index medicus (3) 3
africa (3) 3
analysis (3) 3
antifungal agents - administration & dosage (3) 3
article (3) 3
combination (3) 3
cryptococcus neoformans (3) 3
dosage and administration (3) 3
drug therapy (3) 3
early fungicidal activity (3) 3
fungi (3) 3
hiv infections - drug therapy (3) 3
infections (3) 3
major article (3) 3
management (3) 3
meningitis, cryptococcal - diagnosis (3) 3
outcomes (3) 3
sensitivity and specificity (3) 3
south africa (3) 3
sub-saharan africa (3) 3
therapy (3) 3
aids-related opportunistic infections - microbiology (2) 2
amphotericin (2) 2
amphotericin b - administration & dosage (2) 2
amphotericin b - therapeutic use (2) 2
anemia - pathology (2) 2
antifungal agents - adverse effects (2) 2
antigens (2) 2
antiparasitic agents (2) 2
antiretroviral drugs (2) 2
articles and commentaries (2) 2
assay (2) 2
capsule (2) 2
cerebrospinal-fluid (2) 2
chemical and pharmacologic phenomena (2) 2
cohort (2) 2
combined cohort (2) 2
confidence intervals (2) 2
critical care (2) 2
cryptococcus - immunology (2) 2
cytokines (2) 2
dose-response relationship, drug (2) 2
fluconazole - administration & dosage (2) 2
fluconazole - adverse effects (2) 2
fluconazole - therapeutic use (2) 2
fungal infections (2) 2
guidelines (2) 2
health outcomes (2) 2
hiv-infection (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2014, Volume 370, Issue 26, pp. 2487 - 2498
Data continue to emerge that suggest treating HIV infection as early as possible is beneficial. In this trial assessing the timing of antiretroviral therapy... 
HIGH-DOSE FLUCONAZOLE | MEDICINE, GENERAL & INTERNAL | TUBERCULOUS MENINGITIS | HIV | RECONSTITUTION INFLAMMATORY SYNDROME | DISEASE | ADULTS | INFECTION | COHORT | EARLY MORTALITY | AMPHOTERICIN-B | Drug Administration Schedule | Meningitis, Cryptococcal - drug therapy | Humans | South Africa - epidemiology | AIDS-Related Opportunistic Infections - drug therapy | Anti-Retroviral Agents - adverse effects | Uganda - epidemiology | Male | Cerebrospinal Fluid Otorrhea - immunology | Acquired Immunodeficiency Syndrome - drug therapy | Cause of Death | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Anti-Retroviral Agents - administration & dosage | AIDS-Related Opportunistic Infections - mortality | Survival Analysis | Adult | Female | Leukocyte Count | Acquired Immunodeficiency Syndrome - complications | Amphotericin B - therapeutic use | Antiviral agents | Care and treatment | Dosage and administration | Cryptococcal meningitis | Diagnosis | Research | Antiretroviral drugs | Fluconazole | Hypersensitivity | Mortality | Body weight | Immune reconstitution | Infections | Inflammation | Cerebrospinal fluid | Leukocytes | Medical diagnosis | Antiretroviral therapy | Infectious diseases | Amphotericin B | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Meningitis | Drug therapy
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 68 - 75
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2008, Volume 47, Issue 12, pp. 1556 - 1561
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 9/2009, Volume 49, Issue 5, pp. 702 - 709
Background. Progress in therapy for cryptococcal meningitis has been slow because of the lack of a suitable marker of treatment response. Previously, we... 
Antifungals | Health outcomes | Cryptococcal meningitis | Infectious diseases | Cytokines | HIV | Mortality | Articles and Commentaries | AIDS | Infections | Cerebrospinal fluid | INFECTIOUS DISEASES | RANDOMIZED-TRIAL | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | FUNGAL BURDEN | AMPHOTERICIN-B | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | UGANDA | PRESSURE | FLUCYTOSINE | FLUCONAZOLE | Prognosis | Prospective Studies | Meningitis, Cryptococcal - drug therapy | Humans | Male | Colony Count, Microbial | Thailand | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Dose-Response Relationship, Drug | Time Factors | AIDS-Related Opportunistic Infections - mortality | Adult | Female | Drug Therapy, Combination | Interferon-gamma - cerebrospinal fluid | Meningitis, Cryptococcal - cerebrospinal fluid | AIDS-Related Opportunistic Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Randomized Controlled Trials as Topic | AIDS-Related Opportunistic Infections - cerebrospinal fluid | South Africa | Uganda | Cerebrospinal Fluid - microbiology | Cohort Studies | Usage | HIV (Viruses) | Health aspects | Patient outcomes | Antifungal agents | Drugs | Infection | Fungicidal activity | Immunodeficiency | gamma -Interferon | Data processing | Meningitis | Statistics | Survival
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 03/2014, Volume 58, Issue 5, pp. 736 - 745
Journal Article
Journal Article
Advances in Infectious Diseases, ISSN 2164-2648, 2019, Volume 9, Issue 3, pp. 183 - 196
Journal Article
Advances in Infectious Diseases, ISSN 2164-2648, 2019, Volume 9, Issue 2, pp. 65 - 79
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2015, Volume 59, Issue 12, pp. 7224 - 7231
Journal Article
Journal Article
INFECTION AND IMMUNITY, ISSN 0019-9567, 05/2019, Volume 87, Issue 5
Cryptococcal meningitis (CM) causes high rates of HIV-related mortality, yet the Cryptococcus factors influencing patient outcome are not well understood.... 
DIAGNOSIS | INFECTIOUS DISEASES | PHAGOCYTOSIS | Cryptococcus neoformans | meningitis | VAR. GRUBII | sequence type | AMPHOTERICIN-B | IMMUNOLOGY | cryptococcosis | mouse | pathogenesis | virulence | COMBINED COHORT | CAPSULE | Cryptococcus | RESISTANCE | model | OUTCOMES | human | FLUCONAZOLE
Journal Article